SCHEMBL3448190

SCHEMBL3448190

CC(C)(C)OC(=O)N1CCC(CNC(=O)c2ccc(Cl)cc2)C1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.69
PKM P14618 1/20 0.69
SMN1; SMN2 Q16637 3/20 0.59
HTT P42858 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
ACKR3 P25106 1/20 0.52
KMT2A Q03164 7/20 0.50
KCNH2 Q12809 4/20 0.50
MEN1 O00255 4/20 0.50
CACNA1I Q9P0X4 3/20 0.50
GPR119 Q8TDV5 1/20 0.49
STS P08842 1/20 0.49
ALDH1A1 P00352 1/20 0.49
NAMPT P43490 1/20 0.48
NR1D1 P20393 1/20 0.47
CACNA1H O95180 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
IL1B P01584 1/20 0.47
P2RX7 Q99572 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3448188 1.00 KDM4E (0.69) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL20615733 0.93 KDM4E (0.79) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL14731327 0.89 KDM4E (0.69) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL3448205 0.88 KDM4E (0.67) KDM4EPKMSMN1; SMN2ACKR3KMT2A
SCHEMBL3448200 0.88 KDM4E (0.67) KDM4EPKMSMN1; SMN2ACKR3KMT2A
SCHEMBL14720440 0.87 KDM4E (0.76) KDM4EPKMACKR3KMT2AMEN1
SCHEMBL3448193 0.86 KDM4E (0.60) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL3448195 0.86 KDM4E (0.60) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL653519 0.83 HTT (0.54) KDM4EPKMSMN1; SMN2HTTNPSR1
SCHEMBL653520 0.83 HTT (0.54) KDM4EPKMSMN1; SMN2HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820699-B2 Cyclic amines HOFFMANN-LA ROCHE INC. (US) 2010-10-26 US disclosed
EP-1877404-A2 NOVEL CYCLIC AMINES F. Hoffmann-Roche AG (CH) 2008-01-16 EP disclosed
WO-2006114401-A2 NOVEL CYCLIC AMINES F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 WO disclosed
US-20060247238-A1 Cyclic amines F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247238-A1 Cyclic amines F12, F11, F2 KDM4E 2242/4885PKM 1858/4885SMN1; SMN2 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.